相关实验视频

Updated: Jun 6, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

解开急性髓性白血病治疗的脂质代谢

Cristiana O'Brien^1,2, Courtney L Jones^1,3

¹Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Current opinion in hematology

|November 25, 2024

概括

脂质代谢对于急性髓性白血病 (AML) 的生存和白血病干细胞 (LSC) 功能至关重要. 准脂质通路为AML治疗提供了有前途的新策略.

科学领域:

生物化学生物化学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

脂质在细胞过程中起着至关重要的作用.
变化的脂质代谢在各种癌症中越来越多地被识别出来.

研究的目的:

审查脂质在急性髓性白血病 (AML) 中的多方面的作用.
探索针对AML中的脂质代谢的新型治疗策略,特别是在白血病干细胞 (LSC) 中.

主要方法:

关于人类白血病中脂质代谢的最新研究的综述.
专注于直接评估脂质作为LSC中的代谢物.

主要成果:

脂质代谢对LSC功能和AML存活至关重要,影响能量生产,膜组成,信号和铁亡.
脂质重新连接有助于AML的代谢可塑性和治疗反应.
细胞异质性和脂质相关蛋白质的非正规作用在AML中很重要.

结论:

脂质代谢对于理解和治疗针对AML至关重要.
对脂质稳态动态的进一步研究可以揭示AML和LSC的新型治疗点.
准脂质代谢有可能改善AML患者的治疗结果.

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

相关概念视频

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...